Effects of maternal obesity and gestational diabetes on offspring health
母亲肥胖和妊娠糖尿病对后代健康的影响
基本信息
- 批准号:7617987
- 负责人:
- 金额:$ 4.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-02-01 至 2011-01-31
- 项目状态:已结题
- 来源:
- 关键词:8 year oldAdverse effectsAfricanAfrican AmericanAmericanAreaAttenuatedAuthorization documentationBody CompositionBody fatBoxingChildChildhoodChronicClinical ResearchCommunitiesComorbidityDiabetic intrauterine environmentDietDietary intakeDyslipidemiasEatingEnrollmentEnsureEnvironmentEpigenetic ProcessExhibitsExposure toFamilyFastingFatty acid glycerol estersFemale of child bearing ageGenotypeGestational DiabetesHealthHigh Density Lipoprotein CholesterolHigh PrevalenceHome environmentHormonesHourHypertriglyceridemiaInpatientsInsulinInsulin ResistanceIntakeInterleukin-6LDL Cholesterol LipoproteinsLipidsMeasuresMetabolicMetabolic DiseasesMothersNutritionalObesityOverweightParentsPhysical activityPopulationPregnancyRecruitment ActivityRelative (related person)ReportingResearchRiskSatiationTestingUnited StatesVisitWeightWomanblood glucose regulationblood lipidcytokinediabetes riskdisorder riskenvironmental interventionfeedingghrelinglucagon-like peptide 1glucose tolerancehigh riskin uteroinsulin secretioninsulin sensitivityoffspringprenatal exposuretransmission process
项目摘要
DESCRIPTION (provided by applicant): Over half of all women of child-bearing age are overweight or obese, and maternal obesity increases the risk of developing gestational diabetes mellitus (GDM), which is found in 2-5% of pregnancies in the United States. Children born from pregnancies complicated by maternal obesity and/or GDM are at increased risk themselves for chronic obesity and metabolic health problems such as insulin resistance. African American (AA) children are at particular risk given the high prevalence of obesity among AA women (70% of AA women of child-bearing age are overweight or obese), and the comorbidity between obesity and GDM. The intrauterine environment provides a mechanism through which obesity and diabetes risk may be transmitted from mother to child. The proposed research aims to investigate the independent and interactive effects of maternal obesity and of GDM on the body composition and metabolic health of AA children. We hypothesize that children exposed to an obesogenic and/or diabetic intrauterine environment will have more body fat, greater insulin secretion and lower insulin sensitivity, dyslipidemia, increased cytokine levels, and reduced satiety hormone levels. We will recruit AA women for whom information is available regarding their glucose tolerance during pregnancy, and seek permission to enroll their 5-8 year-old children in our study. Children will be grouped according to their mothers' weight (obese vs. normal weight) and GDM (GDM or non-GDM) status during pregnancy. During an inpatient clinical research center visit to ensure controlled food intake conditions, children's body composition will be assessed by dual-energy x-ray absorptiometry (DXA), their blood lipid, cytokine, and satiety hormone profiles will be obtained, and their insulin sensitivity, secretion and clearance assessed via a mixed-meal tolerance test. In addition, we will measure children's physical activity via accelerometers, and their dietary intake via three 24-hour recalls, to determine whether any between group differences in these variables contribute to differences in body composition and metabolic health. By gaining an understanding of the independent and interactive effects of maternal obesity and of GDM on pediatric health, we can better identify the population at greatest risk for chronic health problems before they develop, and may be able to elucidate mechanisms to overcome the adverse effects of prenatal exposure to obesity and/or GDM.
Relevance: Ultimately, this and subsequent related research will yield information regarding the manner in which obesity and diabetes risk are transmitted, and will identify nutritional and environmental interventions to inhibit the epigenetic transmission of obesity and metabolic disease.
描述(由申请人提供):超过一半的育龄妇女超重或肥胖,孕产妇肥胖会增加患妊娠期糖尿病 (GDM) 的风险,在美国,2-5% 的孕妇患有妊娠期糖尿病 (GDM)。国家。患有母亲肥胖和/或 GDM 的妊娠所生的儿童本身患慢性肥胖和代谢健康问题(例如胰岛素抵抗)的风险增加。鉴于非裔美国人 (AA) 女性肥胖率较高(70% 的 AA 育龄女性超重或肥胖)以及肥胖与妊娠期糖尿病 (GDM) 的合并症,非裔美国人 (AA) 儿童面临的风险尤其高。子宫内环境提供了一种机制,肥胖和糖尿病风险可以通过该机制从母亲传播给孩子。拟议的研究旨在调查母亲肥胖和 GDM 对 AA 儿童的身体成分和代谢健康的独立和交互影响。我们假设,暴露于致肥胖和/或糖尿病宫内环境的儿童将有更多的体脂、更多的胰岛素分泌和更低的胰岛素敏感性、血脂异常、细胞因子水平增加和饱腹感激素水平降低。我们将招募 AA 女性,她们可以获得有关怀孕期间葡萄糖耐量的信息,并寻求许可将她们的 5-8 岁孩子纳入我们的研究。将根据母亲的体重(肥胖与正常体重)和怀孕期间的 GDM(GDM 或非 GDM)状态对儿童进行分组。在住院临床研究中心访问期间,为了确保控制食物摄入条件,将通过双能 X 射线吸收测定法 (DXA) 评估儿童的身体成分,获得他们的血脂、细胞因子和饱腹感激素概况,以及他们的胰岛素敏感性、分泌和清除通过混合膳食耐受性测试进行评估。此外,我们将通过加速度计测量儿童的身体活动,并通过 3 次 24 小时回忆来测量他们的饮食摄入量,以确定这些变量的组间差异是否会导致身体成分和代谢健康的差异。通过了解孕产妇肥胖和 GDM 对儿科健康的独立和交互影响,我们可以在慢性健康问题出现之前更好地识别出慢性健康问题风险最大的人群,并可能能够阐明克服孕产妇肥胖和 GDM 不利影响的机制。产前暴露于肥胖和/或 GDM。
相关性:最终,这项研究和后续的相关研究将提供有关肥胖和糖尿病风险传播方式的信息,并将确定营养和环境干预措施,以抑制肥胖和代谢疾病的表观遗传传播。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paula Catherine Chandler-Laney其他文献
Paula Catherine Chandler-Laney的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paula Catherine Chandler-Laney', 18)}}的其他基金
Offspring Neurodevelopment and Growth after Early Antihypertensive Therapy OR Preeclampsia in Women with Chronic Hypertension and Pregnancy (CHAP Child).
慢性高血压和妊娠妇女(CHAP 儿童)早期抗高血压治疗或先兆子痫后的后代神经发育和生长。
- 批准号:
10745527 - 财政年份:2023
- 资助金额:
$ 4.51万 - 项目类别:
Mechanisms Underlying the Association between Maternal and Offspring Obesity
母亲和后代肥胖之间关联的机制
- 批准号:
8325689 - 财政年份:2011
- 资助金额:
$ 4.51万 - 项目类别:
Mechanisms Underlying the Association between Maternal and Offspring Obesity
母亲和后代肥胖之间关联的机制
- 批准号:
8468698 - 财政年份:2011
- 资助金额:
$ 4.51万 - 项目类别:
Mechanisms Underlying the Association between Maternal and Offspring Obesity
母亲和后代肥胖之间关联的机制
- 批准号:
8670734 - 财政年份:2011
- 资助金额:
$ 4.51万 - 项目类别:
Mechanisms Underlying the Association between Maternal and Offspring Obesity
母亲和后代肥胖之间关联的机制
- 批准号:
8190273 - 财政年份:2011
- 资助金额:
$ 4.51万 - 项目类别:
Effects of maternal obesity and gestational diabetes on offspring health
母亲肥胖和妊娠糖尿病对后代健康的影响
- 批准号:
7752837 - 财政年份:2008
- 资助金额:
$ 4.51万 - 项目类别:
Effects of maternal obesity and gestational diabetes on offspring health
母亲肥胖和妊娠糖尿病对后代健康的影响
- 批准号:
7405875 - 财政年份:2008
- 资助金额:
$ 4.51万 - 项目类别:
相似国自然基金
儿童药品不良反应主动监测中时序处理策略的方法学研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于真实世界医疗大数据的中西药联用严重不良反应监测与评价关键方法研究
- 批准号:82274368
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于隐狄利克雷分配模型的心血管系统药物不良反应主动监测研究
- 批准号:82273739
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于真实世界数据的创新药品上市后严重罕见不良反应评价关键方法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
OR10G7错义突变激活NLRP3炎症小体致伊马替尼严重皮肤不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Stress, Self-Regulation and Psychopathology in Middle Childhood
童年中期的压力、自我调节和精神病理学
- 批准号:
9245718 - 财政年份:2015
- 资助金额:
$ 4.51万 - 项目类别:
Stress, Self-Regulation and Psychopathology in Middle Childhood
童年中期的压力、自我调节和精神病理学
- 批准号:
8888711 - 财政年份:2015
- 资助金额:
$ 4.51万 - 项目类别:
Islet Dysregulation in Infants with Congenital Hyperinsulinism
先天性高胰岛素血症婴儿的胰岛失调
- 批准号:
8764054 - 财政年份:2014
- 资助金额:
$ 4.51万 - 项目类别:
Urgent Versus Post-Stabilization ART in HIV+ Children with Severe Co-infection
严重合并感染 HIV 儿童的紧急 ART 与稳定后 ART
- 批准号:
8543994 - 财政年份:2012
- 资助金额:
$ 4.51万 - 项目类别:
Parent Behavior and Child Adjustment Across Cultures
跨文化的父母行为和儿童适应
- 批准号:
7822905 - 财政年份:2008
- 资助金额:
$ 4.51万 - 项目类别: